泰格医药2025年上半年营业收入为32.5亿元,同比下降3.21%;归母净利润为3.83亿元,同比下降22.22%;扣非归母净利润为2.11亿元,同比下降67.09%。公司自2012年上市以来累计现金分红24.58亿元。财报鹰眼预警系统分析显示,公司在业绩质量、盈利能力等方面存在多个需要关注的问题:营业收入下降,扣非归母净利润增速持续下滑,税金及附加与营业收入变动背离,存货增速高于营业成本和营业...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.